Editor-in-Chief: Godefridus J. Peters
Journal Rank: Impact Factor 2023: 4.6 - Q1 (ONCOLOGY); CiteScore 2024: 8.3 - Q1 [Pharmacology(medical)]
Submission to first decision: 10 days

Cancer Drug Resistance

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN

Articles

Most Recent | Most Viewed | Most Downloaded

Fibroblast growth factor receptor alterations and resistance mechanisms in the treatment of pediatric solid tumors

Open Access Original Article DOI: 10.20517/cdr.2024.208 5 Jun 2025
Views: Downloads:
Download PDF

Acquired resistance to molecularly targeted therapies for cancer

Open Access Review DOI: 10.20517/cdr.2024.189 4 Jun 2025
Views: Downloads:
Download PDF

PER2 expression and cellular localization play a critical role in tumor aggressiveness and drug resistance in an in vitro model of hepatocellular carcinoma

Open Access Original Article DOI: 10.20517/cdr.2024.193 2 Jun 2025
Views: Downloads:
Download PDF

ZEB2 upregulation modulates the polarization of TAMs toward the immunosuppressive state in EGFR-TKI-resistant NSCLC

Open Access Original Article DOI: 10.20517/cdr.2024.206 28 May 2025
Views: Downloads:
Download PDF

Advances in the application of patient-derived xenograft models in acute leukemia resistance

Open Access Review DOI: 10.20517/cdr.2025.18 27 May 2025
Views: Downloads:
Download PDF

Recent advances in access to overcome cancer drug resistance by nanocarrier drug delivery system

Open Access Review DOI: 10.20517/cdr.2023.16 19 Jun 2023
Views: Downloads:
Download PDF

Review of 5-FU resistance mechanisms in colorectal cancer: clinical significance of attenuated on-target effects

Open Access Review DOI: 10.20517/cdr.2022.136 28 Apr 2023
Views: Downloads:
Download PDF

Anti-BCMA novel therapies for multiple myeloma

Open Access Review DOI: 10.20517/cdr.2022.138 21 Mar 2023
Views: Downloads:
Download PDF
For Readers

Add your e-mail address to receive forthcoming Issues of this journal:

Articles Collection
This marks a notable 25.8% increase from last year’s score of 6.6, underscoring the CDR’s rising academic impact and global recognition.
In honor of National Cancer Survivors Month 2025, Cancer Drug Resistance (CDR) is offering a limited-time APC discount to support researchers in the vital field of cancer drug resistance.
We are thrilled to announce that Prof. Baiyong Shen, a globally recognized leader in pancreatic cancer research and Vice President of Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, has officially joined Cancer Drug Resistance as an Associate Editor.
The webinar is scheduled for 7th May as an extension of the special issue.
We warmly welcome your participation and contributions.
In celebration of International Women’s Day, this special collection highlights groundbreaking research from 2023 - 2024, led by female first or corresponding authors in our journal.

Interview with Professor David A. Gewirtz: Exploring Breakthroughs in Cancer Drug Resistance and Treatment [Embedded Auto-Generated Subtitles]

NaN
Articles Collection
Cancer Drug Resistance
ISSN 2578-532X (Online)

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles will preserved here permanently:

https://www.portico.org/publishers/oae/